Friday, May 24, 2013
Submit a News Story
Cancer Stem Cells Isolated from Kidney Tumours
Published: Friday, December 14, 2012
Last Updated: Friday, December 14, 2012
Scientists have isolated cancer stem cells that lead to the growth of Wilms’ tumours, a type of cancer typically found in the kidneys of young children.
Full access to this article is for registered users only.
is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.
Biomarkers Found for Major Depressive Disorder
New research highlights biological and genetic markers associated with improved response to adjunctive L-Methylfolate in management of depression.
Biomarkers Discovered for Inflammatory Bowel Disease
Researchers have identified a number of biomarkers for inflammatory bowel disease (IBD), which could help with earlier diagnosis and intervention.
Your Immune System: On Surveillance in the War Against Cancer
Wake Forest Baptist Research looks at gene expression profiling in breast cancer.
Agilent Technologies Announces Winner of Fifth Annual Early Career Professor Award
Assistant Professor at Northwestern Recognized for Cancer Diagnostics Research.
Gene Discoveries Give Hope Against 'Brittle Bone' Disease
Scientists pinpoint mutation that appears to cause severe forms of bone loss.
Two MIT Professors Named Howard Hughes Medical Institute Investigators
Peter Reddien and Aviv Regev are among 27 top biomedical scientists selected nationwide.
microRNA Cooperation Mutes Breast Cancer Oncogenes
Turning up a few microRNAs a little may offer as much anti-breast-cancer activity as turning up one microRNA a lot – and without the unwanted side effects.
NYSCF Scientists Create Personalized Bone Substitutes from Skin Cells
For treatment of large bone defects and traumatic injuries.
Unusual Comparison Nets New Sleep Loss Marker
Paul Shaw, PhD, a researcher at Washington University School of Medicine in St. Louis, uses what he learns in fruit flies to look for markers of sleep loss in humans.
Lucigen Corporation and Research Corporation Technologies Announce Partnership
Partnership to commercialize and distribute the CleanColi™ Expression System, the first Escherichia coli (E. coli)-based recombinant system that lacks unwanted endotoxin.
Advertise On This Site
Terms & Conditions
©2013 Technology Networks
, all rights reserved.